FAQs

Peptides are short sequences of amino acids found naturally in the body, where they contribute to a range of biological functions. All products we offer are intended exclusively for laboratory research use.

No. Peptides and steroids are two entirely different classes of molecules with different chemistry, structure, and mechanism of action. Peptides are short chains of amino acids linked by peptide bonds — they are typically water-soluble and interact with receptors on the surface of the cell. Steroids, by contrast, are lipid-based compounds built around a four-ring carbon skeleton derived from cholesterol; they usually cross the cell membrane and bind to receptors inside the cell. Their regulatory classification also differs significantly. In short, a peptide is not a steroid, and calling one a version of the other is scientifically inaccurate.

Peptides sit at a useful intersection between chemistry and biology. They are large enough to carry highly specific biological information, yet small enough to be synthesized precisely in a laboratory. That combination makes them powerful tools across a wide range of research areas — including receptor binding studies, mapping of signaling pathways, development of analytical reference standards, and investigation of cellular processes such as metabolism, immune regulation, tissue maintenance, and cell communication. Their specificity and structural tunability are exactly what make peptides a central subject of modern biochemistry, pharmacology, and molecular biology research.

A polypeptide is a single, unbranched chain of amino acids joined together by peptide bonds. It is essentially a longer peptide. Shorter chains — typically between 2 and 50 amino acids — are usually called peptides, while longer chains are called polypeptides. When one or more polypeptide chains fold into a stable, functional three-dimensional structure, the result is what we call a protein. So the progression goes: amino acid → peptide → polypeptide → protein. The exact length cutoffs between these terms are not strictly defined and can vary between sources.

ARA-290, also known as cibinetide in the literature, is a short peptide derived from the tissue-protective region of erythropoietin. It is studied because it appears to engage protective signaling without behaving like erythropoietin in the classic red-blood-cell sense. For site copy, it should be presented as a research peptide only.

AOD-9604 is most often studied in relation to fat metabolism, lipolysis, and body-weight regulation in experimental models. It is usually distinguished from full HGH by the fact that researchers investigate it for metabolic effects without assuming the broader growth-promoting actions of native growth hormone.

Researchers usually investigate ARA-290 in models involving inflammation, tissue protection, and neuropathic or matrix-related signaling. A key point is that it is generally discussed as a non-erythropoietic EPO-derived peptide, meaning the research interest is protective signaling rather than stimulation of red blood cell production.

This blend is usually presented for experimental work involving connective tissue, extracellular-matrix signaling, and cellular-migration research. Researchers who choose a blend like this are generally looking at complementary pathways, but the exact value depends on the stated ingredient ratio, total milligrams, and the quality documents supplied with the lot.

Researchers would usually frame this blend around musculoskeletal, connective-tissue, and cartilage-related signaling. Because it is a combination product, the most important practical detail is the exact milligram breakdown of each ingredient; that is what determines whether the blend matches a study design.

Cagrilintide is usually studied in relation to incretin and metabolic receptor signaling, amylin-receptor binding, and gastric-emptying physiology in experimental models. It is also often discussed alongside GLP-1-based research because both areas intersect around metabolic receptor signaling.

CardioGen is generally described as a peptide bioregulator associated with cardiac-tissue research. It belongs to the short-peptide bioregulator family rather than the larger class of growth-hormone secretagogues or incretin analogs. Because naming and sourcing can vary by supplier, it is best described conservatively as a research-use cardiac peptide complex.

CJC-1295 with DAC is a long-acting analog of growth hormone-releasing hormone. The DAC portion refers to a drug-affinity complex added to prolong circulation time, which is why it is usually distinguished from shorter-acting GHRH analogs. It should be presented as a research peptide for endocrine signaling studies only.

This blend is usually studied for pulsatile growth-hormone release, GH/IGF-1 signaling, and experimental models of endocrine signaling. The exact behavior of the blend depends on whether the CJC component is DAC or non-DAC, since that changes its half-life and pulse pattern.

Researchers typically study CJC-1295 with DAC for its effect on the GH/IGF-1 axis and for sustained stimulation of endogenous growth-hormone release. In FAQ copy, the useful distinction is that it is designed for longer activity than non-DAC versions, which affects how researchers think about pulse pattern and study timing.

CJC/IPA Blend combines a GHRH analog such as CJC-1295 with Ipamorelin, a ghrelin-receptor agonist. The blend is meant to bring together two different upstream pathways involved in endogenous growth-hormone signaling. It is described as a research blend used in endocrine signaling studies.

Epithalon, often also spelled Epitalon, is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It is one of the better-known bioregulator peptides in cellular aging research discussions. It is a research peptide investigated in cellular-aging and regulatory-biology models.

A blend with this naming is usually discussed in relation to dermal matrix research, collagen-related signaling, and extracellular-matrix remodeling. Verify the exact active ingredients before use in a study, because that determines whether the blend fits a specific research objective.

GHK-Cu is a copper-binding tripeptide, short for glycyl-L-histidyl-L-lysine copper. It is one of the most recognized peptides in dermal matrix and cellular-migration research because copper binding changes its biological activity. On a research website, it is described as a laboratory peptide studied for extracellular-matrix and remodeling pathways.

Epithalon is commonly studied in relation to telomerase activity, cell senescence, pineal signaling, and broader cellular-aging pathways. It appears in experimental literature focused on cellular aging, senescence, and cellular regulation; it is not represented as reversing aging.

Glow-70 Blend is a branded multi-compound research formula positioned around dermal matrix and extracellular-matrix research. Because branded blend names are not standardized across the market, the safest description is that it is a proprietary laboratory blend whose exact ingredient list and milligram split should be confirmed on the product page or COA.